Erlonat Tablet (Erlotinib)

What is Erlonat Tablet (Erlotinib)?

Erlotinib Tablet, also known by the brand name Erlonat or Tarceva, is a medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs) and works by inhibiting the activity of a specific protein called epidermal growth factor receptor (EGFR). By blocking EGFR, erlotinib helps to slow down the growth and spread of cancer cells.

Erlotinib is a medication used in the treatment of certain types of cancer, including non-small cell lung cancer. It is available in various strengths, including 150 mg tablets. Erlotinib tablet manufacturers can vary depending on the region, as several pharmaceutical companies produce this medication. Some commonly known manufacturers of Erlotinib tablets include Natco Pharma and Sun Pharmaceutical Industries. About Erlotinib tablet price, we provide the best deals on Erlotinib, ensuring competitive prices and value for money.

Uses of Erlonat Tablet (Erlotinib)

Erlotinib is used to treat metastatic-small cell lung cancer, as first-line treatment, maintenance treatment, or after the failure of one previous chemotherapy. It's also used to treat locally advanced, unresectable (which can not be removed by surgery), or metastatic ( cancer that has spread) pancreatic cancer in combination with another medicine called gemcitabine.

How Erlonat works

Erlotinib has a place with a class of meds called tyrosine kinase inhibitors. It works by precluding the activity of a protein called epidermal growth factor and thereby stops the growth and spread of cancer cells.

Common side effects of Erlonat Tablet (Erlotinib)

Dry skin, cough, fatigue, alopecia, nausea, folliculitis, Infection, liver function test abnormalities, abdominal pain, anorexia, dyspepsia, puking, conjunctivitis, depression, skin issues., acne, rigor, pruritus, diarrhea, stomatitis, neuropathy, rash, paronychia, dyspnea, serious lung infection, cerebral pain, gastrointestinal dying, weight changes, fart.

Precaution of Erlonat Tablet (Erlotinib)

Precautions should be taken while using erlotinib (Tarceva). It is important to inform your healthcare provider about any pre-existing medical conditions, such as liver disease or kidney problems, as well as any medications you are currently taking, including over-the-counter drugs and herbal supplements. Additionally, erlotinib may cause certain side effects such as skin rash, diarrhea, nausea, and changes in liver function. It is crucial to follow the prescribed dosage and to notify your doctor of any unexpected or severe side effects.

Expert advice

Erlotinib tablets should be taken moreover 1 hour before or 2 hours after ingestion of food. Erlotinib isn't suggested for kids and teenagers under 18 years old. Stop smoking and use reasonable prophylactic measures while on erlotinib treatment. Try not to begin erlotinib assuming you use contact focal points, have had eye issues (ulcers in front facing a piece of the eye, dry eyes, irritation in front-facing part of the eye), liver or kidney issues, Gilbert's condition (a liver problem that causes expanded bilirubin), prejudice to certain sugars, are pregnant or bosom taking care of. Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or shelling of skin, severe pain in the abdomen, acute or adding pain, and reddishness in the eye, blurred vision or sensitivity to light, increased eye watering.

Constantly asked questions

Erlonat Tablet (Erlotinib)

Q. Is erlotinib/Tarceva safe during pregnancy?

Erlotinib might hurt the embryo and is consequently not suggested for use during pregnancy. If it's not too much trouble, follow your doctor's recommendation in regard to its utilization.

Q. Is erlotinib safe during lactation?

Erlotinib may not be alright for a bosom-taken-care of newborn child. It should only be used if no other indispensable medicine is available. Kindly follow your doctor's recommendation with respect to its utilization.

Q. Is erlotinib cytotoxic, chemotherapeutic medicine, birth, or monoclonal antibody?

Erlotinib isn't a cytotoxic, chemotherapy medicine, or monoclonal antibody. Erlotinib is a birth tyrosine kinase inhibitor.

Q. Is erlotinib FDA-approved?

Yes, erlotinib is approved by FDA.

Q. Does erlotinib cause neutropenia?

Yes, erlotinib can beget neutropenia.

Q. How long does erlotinib work?

A solitary portion of erlotinib works for around a day and a half.